SciELO - Scientific Electronic Library Online

 
vol.17 issue3Chemotherapy-induced cardiotoxicity at the Instituto Nacional de Enfermedades Neoplásicas 2012-2016Prevalence and factors associated with fragility syndrome in older adults attending the EsSalud primary health care service, January - April 2015. Chiclayo, Peru author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Horizonte Médico (Lima)

Print version ISSN 1727-558X

Abstract

COTUA URZOLA, Juan Camilo et al. Determination of valproic acid dose level and influence of enzyme-inducing and non-enzyme-inducing drugs in volunteer patients of the city of Mérida, Venezuela. Horiz. Med. [online]. 2017, vol.17, n.3, pp.29-34. ISSN 1727-558X.  http://dx.doi.org/10.24265/horizmed.2017.v17n3.06.

Objective: To determine valproic acid level/dose ratio (ND) and the influence of enzyme-inducing and non-enzymeinducing drugs in volunteer patients of the city of Mérida, Venezuela. Materials and methods: An experimental, observational, prospective, cross-sectional study was conducted at the Hospital de Mérida, Venezuela. After undergoing the inclusion and exclusion criteria process, patients signed an informed consent individually and voluntarily. The protocol consisted in collecting blood from 88 patients (42 males y 46 females) from 16 to 68 years old, who had partial or generalized seizures, and were receiving 3.97-38.04 mg/kg of valproic acid (AVP) twice a day as monotherapy or combination therapy with carbamazepine (CBZ), phenobarbital (PB), phenytoin (PHT), lamotrigine (LTG) and oxcarbazepine (OXC). A sample was taken after four weeks of treatment, in the fasting state and before the administration of the medication of the day. Afterwards, plasma concentration was determined through a radioimmunoassay method. The ND was established using the plasma concentration data. Results: AVP monotherapy showed a mean plasma concentration of 64.94 mg/l (SD 31.7) and ND of 4.32 (SD 2.1). Combination therapy with AVP+CBZ+PB showed an ND of 2.31 (SD 0.06), combination therapy with AVP+PB+PHT showed an ND of 2.46 (SD 0.43) and combination therapy with AVP+PB+OXC showed an ND of 4.63 (SD 3.12). Conclusions: The administration of concomitant drugs affected plasma concentration and AVP ND in a group of patients of the Hospital de Mérida, Venezuela.

Keywords : Level/dose ratio (ND); valproic acid; enzyme-inducing drugs; non-enzyme-inducing drugs.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )